# Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer

> **NCT01134497** · PHASE2 · WITHDRAWN · sponsor: **Cardiff University**

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** ZD4054

## Key facts

- **NCT ID:** NCT01134497
- **Lead sponsor:** Cardiff University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2011-08-16
- **Final completion:** 2011-08-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New information on IMP affected the cost/benefit ratio
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134497, "Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01134497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*